Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol

Completed · Phase 4

Conditions studied: Hypercholesterolemia

In brief

Assess the efficacy of WelChol® plus Zetia® in treating patients with high cholesterol

Key facts

Study ID

NCT00185107

Run by

Daiichi Sankyo

People needed

45

Starts

2005-03-01

Expected to finish

2005-10-01

Last updated by the study team

2007-09-11

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18-80 years of age, inclusive;
• A history of primary hypercholesterolemia

You may not qualify if…

• Any serious disorders including pulmonary, hepatic, renal, gastrointestinal (including clinically significant malabsorption), uncontrolled endocrine/ metabolic, hematologic/oncologic (within the last 5 years), neurologic and psychiatric diseases that would interfere with the conduct of the study or interpretation of the data;
• Hepatic dysfunction including biliary cirrhosis, unexplained persistent liver function abnormality, and pre-existing gallbladder disease

Where it is running

• Scripps Clinic — San Diego, California, United States
• Renstar Medical Research — Ocala, Florida, United States
• Radiant Research — Overland Park, Kansas, United States
• L-MARC Research Center — Louisville, Kentucky, United States
• Radiant Research — Edina, Minnesota, United States
• Medical Office — Statesville, North Carolina, United States
• Linder Clinical Trial Center — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.